Warning: The NCBI web site requires JavaScript to function. more...
Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.
Sanmartí R, Graell E, Perez ML, Ercilla G, Viñas O, Gómez-Puerta JA, Gratacós J, Balsa A, Gómara MJ, Larrosa M, Cañete JD, Haro I.
Arthritis Res Ther. 2009;11(5):R135. Epub 2009 Sep 2.
Related citations
Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis.
Vittecoq O, Incaurgarat B, Jouen-Beades F, Legoedec J, Letourneur O, Rolland D, Gervasi G, Ménard JF, Gayet A, Fardellone P, Daragon A, Jolivet M, le Loët X, Tron F.
Clin Exp Immunol. 2004 Jan;135(1):173-80.
Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
J Rheumatol. 2007 Aug;34(8):1658-63. Epub 2007 Jul 1.
Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
Coenen D, Verschueren P, Westhovens R, Bossuyt X.
Clin Chem. 2007 Mar;53(3):498-504. Epub 2007 Jan 26.
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J.
Arthritis Rheum. 2008 Jan;58(1):36-45.
Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
Vander Cruyssen B, Nogueira L, Van Praet J, Deforce D, Elewaut D, Serre G, De Keyser F.
Ann Rheum Dis. 2008 Apr;67(4):542-6. Epub 2007 Jul 20.
Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis.
Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letourneur O, Rolland D, Fournié B, Cantagrel A, Jolivet M, Serre G.
Arthritis Rheum. 2002 Aug;46(8):2051-8.
A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis.
van Gaalen FA, Visser H, Huizinga TW.
Ann Rheum Dis. 2005 Oct;64(10):1510-2. Epub 2005 Mar 30.
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall'Aglio AC, Bianchi FB, Bakker-Jonges LE, van Venrooij WJ, Pruijn GJ, Zendman AJ.
Ann Rheum Dis. 2007 Apr;66(4):511-6. Epub 2006 Sep 19.
Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A, Plischke H, Kellner H, Gruber R.
Ann N Y Acad Sci. 2005 Jun;1050:295-303.
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.
Kudo-Tanaka E, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, Harada Y, Katada Y, Ikeue H, Umeshita-Sasai M, Miyatake K, Saeki Y.
Clin Rheumatol. 2007 Oct;26(10):1627-33. Epub 2007 Feb 8.
Antibodies to citrullinated human fibrinogen synthetic peptides in diagnosing rheumatoid arthritis.
Pérez ML, Gómara MJ, Ercilla G, Sanmartí R, Haro I.
J Med Chem. 2007 Jul 26;50(15):3573-84. Epub 2007 Jun 23.
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M.
Arthritis Res Ther. 2006;8(4):R119.
The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.
Arthritis Rheum. 2000 Jan;43(1):155-63.
The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis.
Malakoutikhah M, Gómara MJ, Gómez-Puerta JA, Sanmartí R, Haro I.
J Med Chem. 2011 Nov 10;54(21):7486-92. Epub 2011 Oct 7.
Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins.
Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, Roudier J, Serre G.
Eur J Immunol. 2006 Aug;36(8):2250-63.
A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients.
Aflaky E, Shenavandeh S, Ashraf MJ.
Rheumatol Int. 2010 Feb;30(4):461-6. Epub 2009 Aug 12.
Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases.
Dubucquoi S, Solau-Gervais E, Lefranc D, Marguerie L, Sibilia J, Goetz J, Dutoit V, Fauchais AL, Hachulla E, Flipo RM, Prin L.
Ann Rheum Dis. 2004 Apr;63(4):415-9.
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations.
De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, Boullart L, Serre G, Veys EM, De Keyser F.
Ann Rheum Dis. 2004 Dec;63(12):1587-93.
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
Alexiou I, Germenis A, Ziogas A, Theodoridou K, Sakkas LI.
BMC Musculoskelet Disord. 2007 Apr 20;8:37.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on